BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• Deals

  Immucor Acquires Organ-i Inc.

  June 2, 2014

   · 

  1 min read
• Drug Development

  Oxygen Biotherapeutics, Inc. Announces Formation Of Steering Committee For Phase 3 LEVO-CTS Trial Of Levosimendan

  June 2, 2014

   · 

  1 min read
• Biotech Beach

  Agilent Technologies Inc. Introduces SureSelectQXT Target Enrichment Kits For Same-Day Sample-to-Sequencing

  June 2, 2014

   · 

  1 min read
• Business

  Bayer AG Pays $68 Million Upfront For Orion Corporation’s Prostate Cancer Candidate ODM-201

  June 2, 2014

   · 

  6 min read
• Drug Development

  Merck & Co., Inc. Immune System-Booster MK3475 Effective In Skin, Lung Cancer

  June 2, 2014

   · 

  9 min read
• Deals

  Albany Molecular Research, Inc. (AMRI) Ponies Up $110 Million For OSO BioPharmaceuticals Manufacturing, LLC

  June 2, 2014

   · 

  10 min read
• Pharm Country

  Alexion Pharmaceuticals Inc. Initiates Recall Of Certain Lots Of Intravenous Drug Soliris

  June 2, 2014

   · 

  8 min read
• FDA

  Omeros Corporation Receives FDA Approval Of Omidria™ For Use In Cataract And Other Intraocular Lens Replacement Procedures

  June 2, 2014

   · 

  8 min read
• Bio NC

  600 New Generic Drugs To Spur Mylan Inc.'s Growth

  June 2, 2014

   · 

  1 min read
• Drug Development

  New Detailed Phase 3 Data Show Amgen’s Novel Cholesterol Drug Evolocumab Significantly Reduced LDL Cholesterol

  June 2, 2014

   · 

  16 min read